Charles River 3Q11 3Q Revenues: $277.6 million (+3%) 3Q Earnings: $18.9 million (loss of $25.0 million 3Q10) YTD Revenues: $851.7 million (flat) YTD Earnings: $82.7 million (earnings were $5.9 million YTD10) Comments: Foreign currency exchange favorably impacted sales by 4%. Sales in the Research Models and Services (RMS) segment were $171.5 million in the quarter, (+8%), driven by higher sales of Other Products, which includes the In Vitro and Avian businesses, as well as RMS. Preclinical ...